Health Canada Approves Evrysdi for At-home Treatment

Health Canada Approves Evrysdi for At-home Treatment

Evrysdi (risdiplam) has been approved by Health Canada for the at-home treatment of spinal muscular atrophy (SMA) in people ages 2 months and older. “The Health Canada approval of Evrysdi is a welcome addition in our ability to treat SMA. It is an efficacious...
Scholar Rock Wins US Patent for Apitegromab

Scholar Rock Wins US Patent for Apitegromab

The United States Patent and Trademark Office has granted Scholar Rock a patent for apitegromab, with add-on and combination therapies, for treating muscle conditions such as spinal muscular atrophy (SMA). “We are delighted to have been granted this unique patent that...